Thrombocyte function and the relationship to blood loss and need for transfusion during coronary artery bypass surgery.

Thrombocyte function and the relationship to blood loss and need for transfusion during coronary artery bypass surgery. - Thrombocyte function and transfusion during coronary bypass chirurgie.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34435

Enrollment

100

Registered

2010-08-18

Start date

2010-10-19

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thrombocyte dysfunction during cardiac surgery

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Elective CABG-procedure with use of extracorporale circulation Group 1: Minimum of 5 days use of clopidogrel and aspirin until day of procedure. Group 2: Minimum of 5 days use of aspirin until the day of procedure, but no clopidogrel use for at least 5 days prior to the procedure.

Exclusion criteria

Exclusion criteria: Use of coumarines or (low molecular weight) heparin Clinical or laboratory signs of hemorrhagic diathesis Cardiac failure Renal insufficiency or dialysis Liver failure Chronic alcoholism Age

Design outcomes

Primary

Measure	Time frame
Outcome if the different labortory tests of platelet function Blood loos during and within 24 hours after the surgical procedrue Transfused number of units during and within 24 hours after the surgical procedure	—

Secondary

Measure	Time frame
Correlation between the different thrombocyte function tests in the two studied populations	—

Countries

Netherlands

Outcome results